Skip to main content

Latest Market News — Page 144

Page 144 · 30 stories scored 7+ · newest 4:23 PM ET · How scores work

Tue, Aug 1130 stories
7TLFTandy Leather Factory, Inc.Tandy Leather Swings to Q2 Profit as Margins Hit 64.8%Earnings & guidance · Reuters▲ Positive8DDIDoubleDown Interactive Co., Ltd.DoubleDown Q2 Revenue Beats on WHOW Games Boost, DTC SurgeEarnings & guidance · Reuters▲ PositivePro8VNOVornado Realty TrustVornado Forms $6.2B JV with Citadel's Griffin for 350 Park Avenue Trophy TowerM&A & partnerships · GlobeNewswire▲ PositivePro8FOCLEDAP TMS SAFocalTherics Files for Public Offering, Dilution Risk Hits SharesFinancing · Dow Jones Newswires▼ NegativePro8SNALSnail, Inc.Snail Q2 Revenue Misses by 32% as ARK Franchise Sales SlumpEarnings & guidance · Reuters▼ NegativePro7LENZLENZ Therapeutics, Inc.LENZ Q2 Revenue Hits $5.5M on VIZZ Growth, Loss Widens to $31.9MEarnings & guidance · Reuters● Neutral9NRGVEnergy Vault Holdings, Inc.Energy Vault Q2 Revenue Doubles, Raises 2026 Guidance on AI Data Center DealEarnings & guidance · Reuters▲ PositivePro7SMTISanara MedTech Inc.Sanara MedTech Q2 Revenue Misses Estimates, Posts Net Loss Amid Acquisition CostsEarnings & guidance · Reuters▼ Negative8GWHESS Tech, Inc.ESS Tech Q2 Loss Widens to $0.46/Share, Signs LOI for Strategic DealEarnings & guidance · Reuters▼ NegativePro8PXLWPIXELWORKS, INCPixelworks Q2 Revenue Plunges to $64K After Licensing PivotEarnings & guidance · Reuters▼ NegativePro7CRWVCoreWeave, Inc.CoreWeave Hits Inflection Point as Scale Drives Operating LeverageEarnings & guidance · Dow Jones Newswires▲ Positive7PLRXPLIANT THERAPEUTICS, INC.Pliant Q2 Loss Narrows, Cash Runway Extended to H2 2028; FORTIFY Trial Enrollment Ahead of ScheduleEarnings & guidance · Reuters▲ Positive8PRSOPeraso Inc.Peraso Q2 Loss Widens to $2.22M Despite Revenue Beat; Supply Woes PersistEarnings & guidance · Reuters▼ NegativePro7NNNEXTNAV INC.NextNav Q2 Loss Narrows to $0.24, Revenue Beats EstimatesEarnings & guidance · Reuters▲ Positive7NCMINational CineMedia, Inc.NCMI Q2 Revenue Misses, Dividend Paused Amid Captivate DealEarnings & guidance · Reuters● Neutral8ATEXAnterix Inc.Anterix Q1 Net Income Crushes Estimates on $10.7M License GainEarnings & guidance · Reuters▲ PositivePro8OWLTOwlet, Inc.Owlet Q2 Revenue Jumps 30%, Beats Estimates; Raises Margin OutlookEarnings & guidance · Reuters▲ PositivePro8HRBH&R BLOCK INCH&R Block Beats FY Revenue, Hikes Dividend 10%, Guides FY27 Above ViewsEarnings & guidance · Reuters▲ PositivePro8INTZIntrusion Inc.Intrusion Q2 Revenue Misses Estimates by 21%, Cash Drops to $0.2MEarnings & guidance · Reuters▼ NegativePro8EVLVEvolv Technologies Holdings, Inc.Evolv Technologies Beats Q2 Revenue, Raises 2026 Outlook on Surging AdoptionEarnings & guidance · Reuters▲ PositivePro8GRWGGrowGeneration Corp.GrowGeneration Beats Q2 Sales, Lifts EBITDA Outlook on B2B StrengthEarnings & guidance · Reuters▲ PositivePro7HOURHour Loop, IncHour Loop Posts 3c EPS in Q2, First Look at ProfitabilityEarnings & guidance · Dow Jones Newswires▼ Negative7FTITechnipFMC plcTechnipFMC Wins $75M-$250M Flexible Pipe Contract for Azule's West Hub TailsM&A & partnerships · BusinessWire▲ Positive8ATROASTRONICS CORPAstronics Posts Q2 EPS of $0.75, Topping ExpectationsEarnings & guidance · Dow Jones Newswires▲ PositivePro8ABSIAbsci CorpAbsci Q2 Revenue Misses by 73%, Loss Widens; Cash Runway Extended to H2 2028Earnings & guidance · Reuters▼ NegativePro8BRCBBlack Rock Coffee Bar, Inc.Black Rock Coffee Bar Q2 Revenue Jumps 25% on New Stores, Comps GrowthEarnings & guidance · Reuters▲ PositivePro7SLSSELLAS Life Sciences Group, Inc.SELLAS Q2 Loss Widens to $9.6M as Trial Costs MountEarnings & guidance · Reuters▼ Negative7ERASErasca, Inc.Erasca Q2 Loss Widens to $44M as R&D Costs Surge; Pipeline Timelines UpdatedEarnings & guidance · Reuters▼ Negative8CINTCI&T IncCI&T Posts 21.9% Organic Revenue Growth, Raises Full-Year GuidanceEarnings & guidance · Dow Jones Newswires▲ PositivePro8SEERSeer, Inc.Seer Q2 Revenue Plunges 23% as Funding Headwinds BiteEarnings & guidance · Reuters▼ NegativePro
How Wiseek picks and scores these

How Wiseek curates this list

Every entry started life as licensed wire-service reporting (Reuters, Dow Jones Newswires, and similar publishers) covering ticker-attributable events. Wiseek's editorial pipeline ingests these in real time, runs each headline through our domain-tuned importance scorer, and surfaces only items rated 7 or higher on a 1–10 market-impact scale. Items below 7 are filtered out at the database query so the public feed stays signal-dense.

What "AI-ranked analysis" means

For each item we publish a plain-English summary, a sentiment label (positive / negative / neutral), and a structured list of key events extracted from the underlying source. Score, summary, and sentiment come from Wiseek's in-house models — not generic chatbot output. See our methodology for the full pipeline and our editorial policy for source-attribution standards.

What's not on this page

Generic market commentary, opinion columns, low-impact press releases, and items below the 7-point importance threshold. Wiseek aggregates and scores wire-service headlines; the underlying publishers retain their original reporting and are credited per article.

Track by company

Follow SEC filings and market news for a specific company by visiting its ticker page: AAPL, MSFT, NVDA, TSLA, AMZN, GOOGL, META, JPM, V, UNH, XOM, AVGO, LLY, MA, COST, JNJ, PG, HD, ABBV, MRK, KO, NFLX, AMD, WMT, CVX, BAC — or browse all covered tickers.